Also trades as: PAR.AX (ASX) · $vol 0M
PBIGF OTC
Paradigm Biopharmaceuticals Limited
1W: -86.8%
1M: -98.9%
3M: -99.1%
YTD: -99.4%
1Y: -99.2%
3Y: -99.8%
5Y: -99.9%
$0.00
-0.00 (-17.65%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$31M
+24.2% ▲
5Y CAGR: -18.5%
Total Liabilities
$27M
+698.4% ▲
5Y CAGR: +32.9%
Shareholders Equity
$3M
-83.6% ▼
5Y CAGR: -46.4%
Cash & Investments
$15M
-8.3% ▼
5Y CAGR: -26.3%
Total Debt
$7M
+136648.3% ▲
5Y CAGR: +58.4%
Net Debt
-$8M
+53.3% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $40M | $56M | $18M | $17M | $15M |
| Short-Term Investments | $46K | $46K | $46K | $0 | $72K |
| Cash & ST Investments | $40M | $56M | $18M | $17M | $15M |
| Net Receivables | $7M | $7M | $5M | $6M | $13M |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $47M | $64M | $24M | $24M | $29M |
| Property, Plant & Equip. | $571K | $336K | $190K | $30K | $498K |
| Goodwill & Intangibles | $3M | $3M | $3M | $415K | $905K |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $4M | $3M | $3M | $445K | $1M |
| Total Assets | $51M | $67M | $27M | $25M | $31M |
| — Liabilities — | |||||
| Accounts Payable | $7M | $12M | $3M | $3M | $17M |
| Short-Term Debt | $0 | $0 | $0 | $5K | $7M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $0 | $0 | $2M |
| Total Current Liabilities | $8M | $13M | $3M | $3M | $27M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $76K | $113K | $107K | $154K | $139K |
| Total Non-Current Liabilities | $545K | $350K | $225K | $154K | $501K |
| Total Liabilities | $8M | $13M | $4M | $3M | $27M |
| — Equity — | |||||
| Common Stock | $147M | $210M | $238M | $253M | $290M |
| Retained Earnings | -$114M | -$164M | -$221M | -$236M | -$288M |
| Accumulated OCI | $9M | $7M | $6M | $4M | $2M |
| Total Stockholders Equity | $42M | $54M | $24M | $21M | $3M |
| Total Liabilities & Equity | $51M | $67M | $27M | $25M | $31M |
| — Key Metrics — | |||||
| Total Debt | $617K | $342K | $239K | $5K | $7M |
| Net Debt | -$39M | -$56M | -$18M | -$17M | -$8M |
| Total Investments | $46K | $46K | $46K | $0 | $72K |